Printer Friendly, PDF & Email

Checklist for Implementing, Expanding Research: Reviewing Compliance, Finances, Patient Volume

The Food and Drug Administration’s April draft guidance for diversity in clinical trials is a new area to incorporate, but there are other factors to consider when implementing or expanding research. Here’s a checklist to help organizations help think them over. It was developed by PYA in conjunction with Rhonda Paz, Managing Principal of Clinical Trial Administrators. Contact her at

Clinical Trial Program: Implementation/Expansion Readiness Assessment Checklist

1. Organizational Support

a. Is leadership looking for a new revenue opportunity?

b. Is leadership looking for ways to enhance the organization’s reputation and/or differentiate it from competitors?

c. Is the organization looking for ways to minimize outmigration and attract new patients?

d. Does the organization desire to achieve or maintain specialized accreditations requiring clinical trial participation?

This document is only available to subscribers. Please log in or purchase access.

Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field